subject area of
- Artificial Intelligence-Enhanced Analysis of Retinal Vasculature in Age-Related Macular Degeneration Journal Articles
- Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration Journal Articles
- Canadian preference and trends survey results for anti-VEGF treatment of macular edema. Journal Articles
- Comparative assessment of subretinal hyper-reflective material in patients treated with brolucizumab versus aflibercept in HAWK and HARRIER Journal Articles
- Comparing an electronic clinical information transfer system to traditional fax referrals for patients with suspected neovascular age-related macular degeneration or diabetic macular edema Journal Articles
- Effect of Brolucizumab and Aflibercept on the Maximum Thickness of Pigment Epithelial Detachments and Sub-Retinal Pigment Epithelium Fluid in HAWK and HARRIER. Journal Articles
- Effectiveness at 1 Year of Monthly versus Variable-Dosing Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-related Macular Degeneration Journal Articles
- Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis. Journal Articles
- Efficacy, safety, and treatment burden of treat-and-extend versus alternative anti-VEGF regimens for nAMD: a systematic review and meta-analysis Journal Articles
- Genetic Risk Evaluation in Wet Age-Related Macular Degeneration Treatment Response Journal Articles
- Genetic Risk Factors Are Not Associated with Wet Age-Related Macular Degeneration Treatment Response to Ranibizumab Journal Articles
- IMPACT OF FLUID COMPARTMENTS ON FUNCTIONAL OUTCOMES FOR PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Journal Articles
- Imaging Biomarkers and Their Impact on Therapeutic Decision-Making in the Management of Neovascular Age-Related Macular Degeneration Journal Articles
- Impact of COVID-19 on a real-world treat-and-extend regimen with aflibercept for neovascular age-related macular degeneration Journal Articles
- MANAGEMENT OF RETINAL PIGMENT EPITHELIUM TEAR DURING ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY Journal Articles
- Ozurdex in age-related macular degeneration as adjunct to ranibizumab (The OARA Study) Journal Articles
- PIGMENT EPITHELIAL DETACHMENT THICKNESS AND VARIABILITY AFFECTS VISUAL OUTCOMES IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Journal Articles
- Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation Journal Articles
- Ranibizumab and the eye Journal Articles
- Ranibizumab vs. aflibercept for wet age-related macular degeneration: network meta-analysis to understand the value of reduced frequency dosing Journal Articles
- SUSPENDING TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION IN CASES OF FUTILITY Journal Articles
- Switching to faricimab from the current anti-VEGF therapy: evidence-based expert recommendations. Journal Articles
- The Association between Retinal Thickness Fluctuations and Visual Outcomes under Anti-Vascular Endothelial Growth Factor Therapy: A Systematic Review and Meta-Analysis Journal Articles
- Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? Journal Articles
- Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration. Journal Articles